Inpharma Weekly

, Volume 1573, Issue 1, pp 15–16 | Cite as

Dasatinib: a once-daily option for imatinib-resistant CML

Meeting report


Imatinib Chronic Myeloid Leukaemia Dasatinib Chronic Myeloid Leukaemia Patient Cytogenetic Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2007

Personalised recommendations